Correspondence to M. Kaszkin, Pharmacentrum Frankfurt, Keinikum der J. W. Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany kaszkin@em.uni-frankfurt.de)
scientists reported that a person's risk of a heart attack is doubled if he or she produces a particular version of FLAP, known more technically as 5-lipoxygenase activating protein. A troublesome variant of this protein boosts production of the inflammat